Overview

The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA

Status:
Withdrawn
Trial end date:
2020-01-28
Target enrollment:
Participant gender:
Summary
It's to investigate the efficacy of Zoledronic acid treatment on the early prosthetic fixation in post-menopausal osteoporosis women under cementless total hip arthroplasty after 24-month observation.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Diphosphonates
Zoledronic Acid